Article Information
History
- April 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jonas Björk1,2,
- Malin Inghammar3,
- Mahnaz Moghaddassi4,
- Magnus Rasmussen3,
- Ulf Malmqvist2 and
- Fredrik Kahn3,*
- 1Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden
- 2Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden
- 3Department of Clinical Sciences Lund, Section for Infection Medicine, Skåne University Hospital, Lund University, Lund, Sweden
- 4Social Medicine and Global Health, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
- ↵*Correspondence and reprint requests:
Fredrik Kahn, Department of Clinical Sciences Lund, Section for Infection Medicine, Skåne University Hospital, Lund University, Lund, Sweden, Hälsogatan 3, SE-221 85 Lund, Sweden., E-mail fredrik.kahn{at}med.lu.se
Posted April 21, 2021.
Effectiveness of the BNT162b2 vaccine in preventing COVID-19 in the working age population – first results from a cohort study in Southern Sweden
